These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25851286)

  • 1. Immune disorders in hemodialysis patients.
    Sharif MR; Chitsazian Z; Moosavian M; Raygan F; Nikoueinejad H; Sharif AR; Einollahi B
    Iran J Kidney Dis; 2015 Mar; 9(2):84-96. PubMed ID: 25851286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay Between Innate and Adaptive Immune Dysfunction.
    Losappio V; Franzin R; Infante B; Godeas G; Gesualdo L; Fersini A; Castellano G; Stallone G
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect].
    Köhler H; Girndt M; Dumann H; Klingel R
    Dtsch Med Wochenschr; 1993 May; 118(21):790-5. PubMed ID: 8504715
    [No Abstract]   [Full Text] [Related]  

  • 5. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'?
    Perl J; Unruh ML; Chan CT
    Kidney Int; 2006 Nov; 70(10):1687-93. PubMed ID: 16969388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and causes of immune dysfunction related to uremia and dialysis.
    Hauser AB; Stinghen AE; Kato S; Bucharles S; Aita C; Yuzawa Y; Pecoits-Filho R
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S183-7. PubMed ID: 18552253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Protein-Energy Wasting in the Uremic Milieu.
    Jankowska M; Cobo G; Lindholm B; Stenvinkel P
    Contrib Nephrol; 2017; 191():58-71. PubMed ID: 28910791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological monitoring of chronic hemodialysis].
    Gidenne S; Ceppa F; Robino C; Sarret D; Burnat P
    Ann Biol Clin (Paris); 2000; 58(6):663-74. PubMed ID: 11098163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis holds distinct advantages for 21st century uremia therapy.
    Nose Y; Smith JW; Malchesky PS
    Kidney Int Suppl; 1985 Dec; 17():S131-2. PubMed ID: 3867783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uremic neuropathy in chronic kidney failure with dialysis].
    Ogura Y; Chichihara Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():824-7. PubMed ID: 1315886
    [No Abstract]   [Full Text] [Related]  

  • 11. Uremic encephalopathies: clinical, biochemical, and experimental features.
    Mahoney CA; Arieff AI
    Am J Kidney Dis; 1982 Nov; 2(3):324-36. PubMed ID: 6756130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 14. End-stage renal disease in leprosy.
    Lomonte C; Chiarulli G; Cazzato F; Giammaria B; Marchio G; Losurdo N; Antonelli M; Casucci F; Basile C
    J Nephrol; 2004; 17(2):302-5. PubMed ID: 15293533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition in the elderly patient on dialysis.
    Lacquaniti A; Bolignano D; Campo S; Perrone C; Donato V; Fazio MR; Buemi A; Sturiale A; Buemi M
    Ren Fail; 2009; 31(3):239-45. PubMed ID: 19288330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients.
    Ikizler TA
    Semin Dial; 2004; 17(6):471-8. PubMed ID: 15660578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiographic examination of the pelvis in patients under periodic hemodialysis for terminal uremia].
    Palestini M; Colarieti G; Alessi G; Urso S; Vecchi L; Aleandri M; Teofili MT; Borghese M
    Clin Ter; 1993 Nov; 143(5):375-82. PubMed ID: 8275653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dialysis purity on uremic dyslipidemia.
    Schiffl H; Lang SM
    Ther Apher Dial; 2010 Feb; 14(1):5-11. PubMed ID: 20438514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory function abnormalities in uremic patients].
    Senatore M; Buemi M; Di Somma A; Sapio C; Gallo GC
    G Ital Nefrol; 2004; 21(1):29-33. PubMed ID: 15356844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.